NOWAUTO INC Stock OTC Markets

NWAU

US67012P1093

Biotechnology & Medical Research

Market Closed - OTC Markets 14:51:47 2026-10-09 EDT			5-day change	1st Jan Change
0.000100 ^USD	0.00%		0.00%	-

08-25	Fifty 1 Labs, Inc. acquired Musculoskeletal Recovery Product Line of MSK Signal.	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI

Fifty 1 Labs, Inc. is a biotechnology and life sciences company. The Company focuses on peptide products, peptide discovery, AI-enabled research, and clinical development. It also focuses on peptide science, musculoskeletal health, sports performance, injury recovery, rehabilitation, and evidence-driven wellness. It owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies designed to enhance athletic performance, recovery, and overall health. It has acquired a musculoskeletal recovery product line. The product line includes five key product concepts designed to support the Company's peptide and musculoskeletal health markets. The portfolio includes natural health products focused on connective tissue recovery, inflammation support, post-surgical recovery nutrition, joint and cartilage support, and an investigational BPC-157-focused research platform.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	281K 251K 234K 213K 402K 27.24M 403K 2.81M 1.1M 13.89M 1.06M 1.03M 44.57M	P/E 2009	-0.05x	P/E 2010	-0.01x
Enterprise Value	12.55M 11.21M 10.43M 9.49M 17.91M 1.22B 17.99M 126M 49.19M 619M 47.14M 46.11M 1.99B	EV / Sales 2009	1.86x	EV / Sales 2010	2.41x
Free-Float	47.75%	Yield 2009 *	-	Yield 2010	-

08-25	Fifty 1 Labs, Inc. acquired Musculoskeletal Recovery Product Line of MSK Signal.	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025	CI
01-05	Fifty 1 Labs, Inc. Announces CEO Changes	CI
25-08-14	Fifty 1 Labs, Inc. Announces the Completion of the Largest and Most Comprehensive Study of Sickle Cell Disease	CI
25-07-10	Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling 50 1 Labs, Inc. Toward $50 Million Valuation	CI
25-04-30	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chairman of the Board	CI
25-04-30	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chief Executive Officer	CI
25-04-30	The Fifty 1 Labs Biosentry Division Will Develop State-Of-The-Art Biohazard Sensing Sensors Capable of Detecting Pathogens	CI
25-04-30	UAV Corp. Announces Strategic Partnership with 50 1 Labs, Inc	CI
25-04-08	Uav Corp And Genetic Networks Announce Strategic Collaboration	RE
25-03-20	Fifty 1 Labs, Inc. Appoints Gennaro D'Urso as CEO	CI
25-03-20	Fifty 1 Labs, Inc. Appoints Gennaro D'urso as Chairman	CI

08-26	Fifty 1 Labs, Inc. Acquires MSK Signal Recovery Product Line to Accelerate Growth in the Peptide and Musculoskeletal Health Market	AQ
08-07	Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform	AQ
07-10	Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth	AQ
04-15	Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health	AQ
04-14	Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market	AQ

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.02
5 years	0		0.04
10 years	0		0.4

Manager	Title	Age	Since
Pritpaul Singh Arora CEO	Chief Executive Officer	47	-
Brandon Spikes PSD	President	-	-
Alind Gupta CTO	Chief Tech/Sci/R&D Officer	-	-

NOWAUTO INC Stock OTC Markets

Stocks

NWAU

US67012P1093

Biotechnology & Medical Research

Valuation: NOWAUTO INC

Chart: NOWAUTO INC

Latest news: NOWAUTO INC

Press Releases: NOWAUTO INC

Price Extremes

Managers and Directors: NOWAUTO INC

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Director	Title	Age	Since
Robert Clark BRD	Director/Board Member	49	2025-04-29
Brandon Spikes CHM	Chairman	-	2023-07-11
Curtis Young BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NOWAUTO INC	0.00%	0.00%	-	-	237K
WUXI APPTEC CO., LTD.	-2.59%	-5.70%	+50.69%	+86.86%	70.61B
ARGENX SE	+3.23%	-10.67%	+6.27%	+53.70%	51.01B
LONZA GROUP AG	+1.56%	+1.17%	+8.49%	+31.81%	48.1B
IQVIA HOLDINGS INC.	+0.39%	+0.65%	+31.14%	+28.97%	42.78B
REVOLUTION MEDICINES, INC.	+0.87%	-8.17%	+293.37%	+642.41%	40.67B
BEONE MEDICINES AG	+1.24%	-1.01%	+10.74%	+100.64%	40.3B
CELLTRION, INC.	-2.13%	-1.64%	+8.63%	+46.88%	30.59B
WUXI BIOLOGICS (CAYMAN) INC.	-0.46%	-1.28%	+42.23%	+20.34%	28.16B
BIONTECH SE	+5.32%	+0.06%	-5.00%	-12.78%	24.36B
Average	+0.74%	-2.66%	+49.62%	+110.98%	41.84B
Weighted average by Cap.	+0.56%	-2.94%	+51.35%	+115.57%

	2009	2010
Net sales	5.41M 4.83M 4.5M 4.09M 7.72M 524M 7.75M 54.11M 21.2M 267M 20.32M 19.88M 857M	5.11M 4.56M 4.24M 3.86M 7.29M 494M 7.32M 51.06M 20.01M 252M 19.18M 18.76M 809M
Net income	-2.23M -1.99M -1.85M -1.69M -3.18M -216M -3.2M -22.31M -8.74M -110M -8.38M -8.2M -353M	-1.89M -1.69M -1.57M -1.43M -2.7M -183M -2.71M -18.94M -7.42M -93.47M -7.11M -6.96M -300M
Net Debt	9.96M 8.89M 8.27M 7.52M 14.21M 964M 14.27M 99.55M 39.01M 491M 37.39M 36.57M 1.58B	12.27M 10.96M 10.2M 9.27M 17.51M 1.19B 17.59M 123M 48.08M 606M 46.09M 45.08M 1.94B